$1.73
-0.085-4.7%
Last update: Aug 28, 2:29 PM
Annovis Bio (ANVS) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.46 | $-0.35 | $-0.34 | $-0.37 |
| Actual | $-0.40 | $-0.63 | $-0.39 | $-0.37 |
| Surprise | +13.0% | -80.0% | -14.7% | 0.00% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.35 | $-0.28 | $-0.19 | $-0.15 |
| Revenue | ||||
| Consensus | — | — | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 14, 2026 | $-0.40 | $-0.46 | 13.0 % |
| Q1 | May 15, 2026 | $-0.63 | $-0.35 | -80.0 % |
| Q4 | Mar 16, 2026 | $-0.39 | $-0.34 | -14.7 % |
| Q3 | Nov 12, 2025 | $-0.37 | $-0.37 | 0.00 % |